Original Article Oncology Physical Medicine & Rehabilitation
Effect of vitamin D supplementation on surgical site infection among critically ill adults

Effect of vitamin D supplementation on surgical site infection among critically ill adults

Authors

Adam Kim

Adam Kim

Mayo Clinic, Eswatini

Corresponding
Yusuf Lindqvist

Yusuf Lindqvist

American University of Beirut Medical Center, Tajikistan

Lina Herrera

Lina Herrera

Mayo Clinic, Australia

Daniel Nakamura

Daniel Nakamura

Toronto General Hospital, Haiti

Layla Kim

Layla Kim

American University of Beirut Medical Center, Kuwait

Published

May 31, 2025

Paper ID

PAP-000171

Status

Published

DOI

10.65712/tmj.test000429

Effect of vitamin D supplementation on surgical site infection among critically ill adults

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of surgical site infection to health systems is substantial. Methods: Missing data were handled with multiple imputation. Results: The adjusted odds ratio was 0.53 (95% CI 0.40 to 0.87). Serious adverse events were rare and similar between groups. Conclusion: Residual confounding cannot be excluded.

Introduction

Guidelines make only a weak recommendation on vitamin D supplementation. surgical site infection remains a leading cause of avoidable harm among critically ill adults.

The cost of surgical site infection to health systems is substantial. Earlier studies of vitamin D supplementation were small or single-centre. surgical site infection remains a leading cause of avoidable harm among critically ill adults.

Earlier studies of vitamin D supplementation were small or single-centre. Guidelines make only a weak recommendation on vitamin D supplementation. surgical site infection remains a leading cause of avoidable harm among critically ill adults.

Materials and Methods

The primary outcome was surgical site infection, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

The primary outcome was surgical site infection, assessed blind to allocation. We conducted a pilot feasibility study across 9 centres between 2020 and 2021. Analyses were adjusted for age, sex and baseline severity. Eligible participants were critically ill adults.

Results

Serious adverse events were rare and similar between groups. 3133 participants were included (median age 76 years). 4445 participants were included (median age 59 years).

4618 participants were included (median age 65 years). Effects were consistent across prespecified subgroups. 3431 participants were included (median age 38 years). The adjusted odds ratio was 0.45 (95% CI 0.25 to 0.75).

Serious adverse events were rare and similar between groups. 3531 participants were included (median age 49 years). Effects were consistent across prespecified subgroups.

GroupnEventsRate %
Age ≥ 658533316.5
Centre B2566135.8
Male6196534.8
Age ≥ 651991619.7
Age ≥ 658813137.0
TABLE 1: Baseline characteristics
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in surgical site infection
Shown for critically ill adults; error bars are 95% confidence intervals.

3586 participants were included (median age 36 years). 3899 participants were included (median age 31 years). Effects were consistent across prespecified subgroups.

Discussion

Implementation will depend on staffing, cost and local protocols. These findings suggest that vitamin D supplementation is associated with better surgical site infection in critically ill adults.

Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. Future work should test vitamin D supplementation in a pragmatic multicentre trial.

These findings suggest that vitamin D supplementation is associated with better surgical site infection in critically ill adults. Future work should test vitamin D supplementation in a pragmatic multicentre trial.

Conclusions

Vitamin D supplementation should be considered for critically ill adults to improve surgical site infection.

References

1. Costa X, Haddad O, et al. Home-based cardiac rehabilitation and length of stay. Crit Care Med. 2024;214(9):372-1725.

2. Yilmaz G, Silva E, et al. Nurse-led discharge planning and 30-day readmission. Ann Intern Med. 2025;49(8):201-1510.

3. Nasser P, Zhang C, et al. Pharmacist-led medication review and in-hospital mortality. Pediatrics. 2024;286(4):565-1215.

4. Dubois P, Ibrahim M, et al. Tranexamic acid and 30-day readmission. Lancet. 2017;190(8):23-1366.

5. Lindqvist Z, Osei Q, et al. Continuous glucose monitoring and acute kidney injury. JAMA. 2016;205(3):352-953.

6. Larsen B, Okafor N, et al. High-flow nasal oxygen and time to diagnosis. JAMA. 2011;284(11):508-1373.

Appendices

Ethics approval: IRB-4051.